Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Class II HLA Genotype Association With First-Phase Insulin Response Is Explained by Islet Autoantibodies.

Koskinen MK, Lempainen J, Löyttyniemi E, Helminen O, Hekkala A, Härkönen T, Kiviniemi M, Simell O, Knip M, Ilonen J, Toppari J, Veijola R.

J Clin Endocrinol Metab. 2018 Aug 1;103(8):2870-2878. doi: 10.1210/jc.2017-02040.

PMID:
29300921
2.

Non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients undergoing elective cardioversion.

Itäinen S, Lehto M, Vasankari T, Mustonen P, Kotamäki M, Numminen A, Lahtela H, Bah A, Hartikainen J, Hekkala AM, Airaksinen JKE.

Europace. 2018 Apr 1;20(4):565-568. doi: 10.1093/europace/eux116.

PMID:
29016758
3.

Ketoacidosis at diagnosis of type 1 diabetes: Effect of prospective studies with newborn genetic screening and follow up of risk children.

Hekkala AM, Ilonen J, Toppari J, Knip M, Veijola R.

Pediatr Diabetes. 2018 Mar;19(2):314-319. doi: 10.1111/pedi.12541. Epub 2017 May 23.

PMID:
28544185
4.

Dysregulation of glucose metabolism in preclinical type 1 diabetes.

Veijola R, Koskinen M, Helminen O, Hekkala A.

Pediatr Diabetes. 2016 Jul;17 Suppl 22:25-30. doi: 10.1111/pedi.12392. Review.

PMID:
27411433
5.

[Flatus gone astray and other causes of syncope ].

Hekkala AM, Parikka H.

Duodecim. 2014;130(8):819-21. Finnish.

PMID:
24822332
6.

Insulin secretion and sensitivity in the prediction of type 1 diabetes in children with advanced β-cell autoimmunity.

Siljander HT, Hermann R, Hekkala A, Lähde J, Tanner L, Keskinen P, Ilonen J, Simell O, Veijola R, Knip M.

Eur J Endocrinol. 2013 Sep 14;169(4):479-85. doi: 10.1530/EJE-13-0206. Print 2013 Oct.

PMID:
23904276
7.

T-wave morphology after epinephrine bolus may reveal silent long QT syndrome mutation carriers.

Hekkala AM, Heikki V, Heikki S, Matti V, Lauri T.

J Electrocardiol. 2012 Jul-Aug;45(4):368-72. doi: 10.1016/j.jelectrocard.2012.04.007. Epub 2012 May 4.

PMID:
22560601
8.

Family history of diabetes and distribution of class II HLA genotypes in children with newly diagnosed type 1 diabetes: effect on diabetic ketoacidosis.

Hekkala A, Ilonen J, Knip M, Veijola R; Finnish Paediatric Diabetes Register.

Eur J Endocrinol. 2011 Nov;165(5):813-7. doi: 10.1530/EJE-11-0376. Epub 2011 Sep 2.

PMID:
21890652
9.

Epinephrine bolus test in detecting long QT syndrome mutation carriers with indeterminable electrocardiographic phenotype.

Hekkala AM, Swan H, Viitasalo M, Väänänen H, Toivonen L.

Ann Noninvasive Electrocardiol. 2011 Apr;16(2):172-9. doi: 10.1111/j.1542-474X.2011.00426.x.

PMID:
21496168
10.

Abnormal repolarization dynamics revealed in exercise test in long QT syndrome mutation carriers with normal resting QT interval.

Hekkala AM, Viitasalo M, Väänänen H, Swan H, Toivonen L.

Europace. 2010 Sep;12(9):1296-301. doi: 10.1093/europace/euq184. Epub 2010 Jun 20.

PMID:
20566482
11.

Age-related differences in the frequency of ketoacidosis at diagnosis of type 1 diabetes in children and adolescents.

Hekkala A, Reunanen A, Koski M, Knip M, Veijola R; Finnish Pediatric Diabetes Register.

Diabetes Care. 2010 Jul;33(7):1500-2. doi: 10.2337/dc09-2344. Epub 2010 Apr 22.

12.

Predictive characteristics of diabetes-associated autoantibodies among children with HLA-conferred disease susceptibility in the general population.

Siljander HT, Simell S, Hekkala A, Lähde J, Simell T, Vähäsalo P, Veijola R, Ilonen J, Simell O, Knip M.

Diabetes. 2009 Dec;58(12):2835-42. doi: 10.2337/db08-1305. Epub 2009 Sep 15.

13.

Role of insulin autoantibody affinity as a predictive marker for type 1 diabetes in young children with HLA-conferred disease susceptibility.

Siljander H, Härkönen T, Hermann R, Simell S, Hekkala A, Salonsaari RT, Simell T, Simell O, Ilonen J, Veijola R, Knip M.

Diabetes Metab Res Rev. 2009 Oct;25(7):615-22. doi: 10.1002/dmrr.998.

PMID:
19637309
14.

Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes.

Oresic M, Simell S, Sysi-Aho M, Näntö-Salonen K, Seppänen-Laakso T, Parikka V, Katajamaa M, Hekkala A, Mattila I, Keskinen P, Yetukuri L, Reinikainen A, Lähde J, Suortti T, Hakalax J, Simell T, Hyöty H, Veijola R, Ilonen J, Lahesmaa R, Knip M, Simell O.

J Exp Med. 2008 Dec 22;205(13):2975-84. doi: 10.1084/jem.20081800. Epub 2008 Dec 15.

15.

Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial.

Näntö-Salonen K, Kupila A, Simell S, Siljander H, Salonsaari T, Hekkala A, Korhonen S, Erkkola R, Sipilä JI, Haavisto L, Siltala M, Tuominen J, Hakalax J, Hyöty H, Ilonen J, Veijola R, Simell T, Knip M, Simell O.

Lancet. 2008 Nov 15;372(9651):1746-55. doi: 10.1016/S0140-6736(08)61309-4. Epub 2008 Sep 22.

PMID:
18814906
16.

Fate of five celiac disease-associated antibodies during normal diet in genetically at-risk children observed from birth in a natural history study.

Simell S, Hoppu S, Hekkala A, Simell T, Ståhlberg MR, Viander M, Yrjänäinen H, Grönlund J, Markula P, Simell V, Knip M, Ilonen J, Hyöty H, Simell O.

Am J Gastroenterol. 2007 Sep;102(9):2026-35. Epub 2007 Jun 15.

PMID:
17573785
17.

The effect of antihistamine cetirizine on ventricular repolarization in congenital long QT syndrome.

Hekkala AM, Swan H, Väänänen H, Viitasalo M, Toivonen L.

J Cardiovasc Electrophysiol. 2007 Jul;18(7):691-5. Epub 2007 May 15.

PMID:
17506855
18.
19.

Reproducibility of computerized measurements of QT interval from multiple leads at rest and during exercise.

Hekkala AM, Väänänen H, Swan H, Oikarinen L, Viitasalo M, Toivonen L.

Ann Noninvasive Electrocardiol. 2006 Oct;11(4):318-26.

PMID:
17040280
20.

Ventricular repolarization and heart rate responses during cardiovascular autonomic function testing in LQT1 subtype of long QT syndrome.

Haapalahti P, Viitasalo M, Perhonen M, Mäkijärvi M, Väänänen H, Oikarinen L, Hekkala AM, Salorinne Y, Swan H, Toivonen L.

Pacing Clin Electrophysiol. 2006 Oct;29(10):1122-9.

PMID:
17038145
21.

Effect of physical training on ventricular repolarization in type 1 long QT syndrome: a pilot study in asymptomatic carriers of the G589D KCNQ1 mutation.

Perhonen MA, Haapalahti P, Kivistö S, Hekkala AM, Väänänen H, Swan H, Toivonen L.

Europace. 2006 Oct;8(10):894-8. Epub 2006 Aug 1.

PMID:
16882680
22.

IA-2 antibody isotypes and epitope specificity during the prediabetic process in children with HLA-conferred susceptibility to type I diabetes.

Hoppu S, Härkönen T, Ronkainen MS, Simell S, Hekkala A, Toivonen A, Ilonen J, Simell O, Knip M.

Clin Exp Immunol. 2006 Apr;144(1):59-66.

23.

Natural history of transglutaminase autoantibodies and mucosal changes in children carrying HLA-conferred celiac disease susceptibility.

Simell S, Kupila A, Hoppu S, Hekkala A, Simell T, Ståhlberg MR, Viander M, Hurme T, Knip M, Ilonen J, Hyöty H, Simell O.

Scand J Gastroenterol. 2005 Oct;40(10):1182-91.

PMID:
16265775
24.

Infant feeding patterns in the Finnish type I diabetes prediction and prevention nutrition study cohort.

Erkkola M, Pigg HM, Virta-Autio P, Hekkala A, Hyppönen E, Knip M, Virtanen SM.

Eur J Clin Nutr. 2005 Jan;59(1):107-13.

PMID:
15354198
25.

[Acute myocardial infarction complicating viper bite].

Hekkala AM, Lilleberg J.

Duodecim. 2004;120(11):1320-3. Finnish. No abstract available.

PMID:
15327083

Supplemental Content

Loading ...
Support Center